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Supplemental Materials and Methods 
CLL cases 
Primary neoplastic cells of the 662 CLL cases entering the study were separated by Ficoll-Hypaque 
(Pharmacia, Uppsala, Sweden) density gradient centrifugation, and used either directly or 
cryopreserved until use, as reported.
1
Next generation sequencing (NGS) 
NOTCH1 mutational status was investigated by NGS with an amplicon based strategy. Specific 
primers for NOTCH1 exon 34 and part of 3′ untranslated region (3′ UTR), carrying new mutation 
sites described by Puente et al.,
2
 were designed with the ION Ampliseq designer (Thermo
Scientific, Milan, Italy,  https://www.ampliseq.com/), checked using the Primer3 program,
3,4
 and
modified according to Illumina (San Diego, CA) protocol adding specific adapter sequences (Table 
S1). Amplicon libraries were generated using a modified Illumina protocol. Briefly, multiplex PCR 
products were generated using Phusion High-Fidelity DNA Polymerase (Thermo Scientific, Milan, 
Italy) and subsequently tagged with specific index according to modified procedures for NexteraXT 
(DNALibrary Preparation kit, Illumina). Purified libraries were pooled, and paired-end sequenced 
in a MiSeq instrument (Illumina). The average sequencing coverage was >6000X. Across the whole 
target region, a coverage >1000x was obtained in >93% of the sequence in all samples. 
Bioinformatic workflow 
Sequencing reads were mapped to the human reference genome (GRCh37/hg19) using the Burrows-
Wheeler Aligner–MEM algorithm (version 0.7.10).
5
 Coverage along the targeted regions was 
analyzed using SAMtools (version 1.1).
6
 Reads were filtered with a quality score >30. Variant 
calling was performed using the entire pipeline established on the MiSeq Reporter software (MSR; 
version 2.4.60). Variants found were annotated using ANNOVAR (version 2014Jul14).
7
 Data were 
analyzed with MiSeq reporter (Illumina) and Integrative Genomics Viewer (IGV) software
8,9 
against human genome assembly GRCh37/hg19. The NOTCH1 mutational status was indicated as 
variant allele frequency (VAF, i.e. percentage of NOTCH1 mutated DNA). Synonymous variants 
and polymorphisms described in the Single Nucleotide Polymorphism Database (dbSNP138), with 
a European population frequency higher than 1% (1000 Genomes Project database), were removed. 
NOTCH1 mutations truncating the NOTCH1 protein were considered somatic mutations. Cases 
with truncating NOTCH1 mutations, with a VAF between 45% and 55% were subjected to the cell 
sorting of CD3-positive cell population. In this sorted CD3-positive cell population, NOTCH1 
mutational status was investigated to further confirm the somatic origin of the mutation. The 
sensitivity of the NGS methodology was verified by performing four independent dilution 
experiments (3 somatic mutations and 1 SNP) to define the minimum detectable VAF. The 
approach was able to detect a minimum VAF of 1.3% (Figure S1A-B). 
Verification of detected NOTCH1 mutations 
The presence of c.7541-7542delCT was verified by using an ARMS-PCR strategy detecting the 
presence of the mutation (see Table S2 for primer sequences, and Figure S1C).
1
 The presence of
coding NOTCH1 mutations other than the c.7541-7542delCT was verified by Sanger sequencing 
when clonal (i.e. with a VAF≥12%, Table S3 for primer sequences and Figure S1B),
10
 otherwise,
when subclonal (i.e. with a VAF<12%) with a second independent NGS experiment. The 3′ UTR 
NOTCH1 mutations were verified by a RT-PCR strategy detecting the presence of the aberrant 
splicing in 23/26 cases (Table S4 for primer sequences and Figure S1D). In the remaining 3/26 





Quantitative real-time PCR (QRT-PCR) 
Transcript expression levels the of genes of interest (i.e. MS4A1, B2M) were evaluated as reported.
1
 
Hydrolysis probe for MS4A1 (Hs.PT.56a.24784282) was from Integrated DNA Technologies (IDT, 
Leuven, Belgium). Taqman Gene Expression assays for B2M (Hs00984230_m1), was from Life 
Technologies (Monza, Italy). Reactions were done in triplicate from the same cDNA reaction 
(technical replicates) with FastStart Universal Probe Master (Roche, Milan, Italy) on a CFX96 (Bio-
Rad, Milan, Italy) instrument. The relative amount of each gene was calculated utilizing the 











CD20 expression was evaluated by flow cytometry with a fluorescein isothiocyanate (FITC)-
conjugated anti-CD20 antibody (clone L27, BD Biosciences, Milan, Italy, Table S5).
1
 CD20 levels 
were expressed as Mean Fluorescence Intensity (MFI). Irrelevant isotype-matched antibodies were 
used to determine background fluorescence. Data reproducibility was ensured using as instrumental 
set-up an application setting linked to Cytometer Setup & Tracking Beads (CS&T Beads, BD 
Biosciences) ran daily. All the experiments were analyzed with FACSDiva (BD Biosciences) or 




Western blot (WB) 
WB was performed as reported,
1
 using the following antibodies: anti-NOTCH1 intracytoplasmic 
domain (NICD, Val1744, clone D3B8, CST-Cell Signaling Technology, Leiden, The Netherlands), 
anti-NOTCH1 (clone D1E11, CST), anti-CD20 (clone L26, Abcam, Cambridge, UK), and anti-β-
actin (clone AC-74, Sigma, Milan, Italy) as control (Table S5). Total proteins were extracted in 
RIPA lysis buffer (Santa Cruz Biotechnology, Heidelberg, Germany), quantified through Bradford 
assay (Bio-Rad) and ran in 4-15% SDS-PAGE precast gels (Bio-Rad) prior to transfer to 
nitrocellulose membranes (Trans-Blot Turbo pack, Bio-Rad). Detection was performed with HRP-
conjugated antibodies (GE Healthcare) and ClarityECL (Bio-Rad, Milan, Italy) or ECLprime (GE 
Healthcare, for high sensitivity conditions to detect CD20 expression) on a ChemiDoc Touch 
Imaging System (Bio-Rad). Image analysis was performed with ImageLab software (Bio-Rad). 
 
Cell Sorting 
CLL cells from selected NOTCH1 mutated cases were sorted according to CD20 expression by 





 fractions were selected below the 25
th
 percentile or above the 75
th
 
percentile of CD20 expression, respectively. Sorting was performed utilizing a FACSAriaIII cell 




In-vitro treatment with γ-secretase inhibitor (GSI) 
Purified primary CLL cells (2x10
6
cells/ml) were treated with the γ-secretase inhibitor (GSI L-
685,458, Sigma, 10µM for 6-24 hours). In control experiments, equal volume of dimethyl sulfoxide 
(DMSO) was added. 
 
Complement-dependent-citotoxicity (CDC) assay 
CDC assay was performed in primary CLL, as described.
11
 Residual viable cells were evaluated by 
staining cells with 7-amino-actinomycin-D (BD Biosciences), as described.
11,12
 In particular, 2x10
5
 
primary CLL cells were incubated with rituximab (5µg/ml) or with ofatunumab (5µg/ml) in a final 
volume of 150 µl for 10 min at room temperature prior to the addition of PNHS (25%) and a further 





All statistical analyses were performed with Medcalc software (Medcalc Software, Ostend, 
Belgium). Data were compared using two-sided Student’s t-test for independent or paired (GSI 
treated/untreated) samples, as reported.
1
 Variance similarity between compared groups was tested 
with Fisher’s exact-test. Distribution normality was tested with D’Agostino-Pearson test. A p-value 
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Table S1. Primers for targeted ultra-deep NGS. 
Target Gene Target region Forward primer (5'-3') Reverse primer (5'-3') 
NOTCH1 exon_34 GGGTGGGTTTCAGAAGATGTATCAAAG TGCGCACCAGGTTGTACTC 
NOTCH1 exon_34 AGCGCATGCATCACGACATC CACGTCTGACAGGTAGCCAT 
NOTCH1 exon_34 CTCAAGGCACGGAGGAAGAAGTC GAGGTGGGCCAGTCTCAAAG 
NOTCH1 exon_34 CATCGGGCACCTGAACGT GCAGAGGGTTGTATTGGTTCG 
NOTCH1 exon_34 CAGTTTGAATGGTCAATGCGAGT ACTTTGCTGCTGCTGGATGTTT 
NOTCH1 exon_34 CAGCCACAAAACTTACAGATGCA GTCCACAGGCGAGGAGTAGCT 
NOTCH1 exon_34 ATGGCGGTGCACACTATTCTG ACCGAAGGCTTGGGAAAGGAAG 
NOTCH1 exon_34 TGAGAGCCAGGGTTTTCCTA CCAGGAGCTTTTTGGACTATGC 
Forward primer adapter: TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG 
Reverse primer adapter: GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG 
Forward and reverse primer adapters are designed according to Illumina. 
7 










reverse primer (5'-3') 
NOTCH1 chr9 139390648 CAG>C AACTGGGCTGCGGTCAC TCGGGACGGGGTGAGGA GCTTCCTTTCCCAAGCCTT 
Table S3. Primers for Sanger sequencing of the NOTCH1 gene.
Forward primer (5'-3') Reverse primer (5'-3') Experiment 
GGCCTGCAGTTGGTTAGATTTTC GGGTGCACTCTTGGCATACACA DNA amplification 
AAGGCTTGGGAAAGGAAGC CTCAACCACCTGCCTGGGAT Sequencing 
GGTAGCTCATCATCTGGGACA GCTGCTTCCTCTGGTGATGG Sequencing 
Table S4. Primers for detection of NOTCH1 aberrant splicing in cases with mutations in the 3' UTR. 
Target Gene Target region Forward primer (5'-3') Reverse primer (5'-3') 
NOTCH1 3'_UTR CCTAACAGGCAGGTGATGCT TACTCCTCGCCTGTGGACAA 
8 
Table S5. Antibodies for western blotting and flow cytometry. 
Target Protein Clone Species Conjugation Vendor ID Dilution 
NOTCH1 D1E11 Rabbit CST #3608 1/3000 (WB) 
NICD D3B8 Rabbit CST #4147 1/1000 (WB) 
CD20 L26 Mouse Abcam ab9475 1/500-1/2000 (WB) 
β-Actin AC-15 Mouse HRP Sigma A3854 1/100 000 (WB) 
Anti-Rabbit Donkey HRP GE Healthcare NA-934 1/3000 (WB) 
Anti-Mouse Sheep HRP GE Healthcare NA-931 1/1000-1/3000 (WB) 
Mouse Isotype MOPC-21 Mouse PE BD 555749 20ul/test (Flow) 
CD20 L27 Mouse PE BD 345793 20ul/test (Flow) 
CD20 L27 Mouse FITC BD 345792 20ul/test (Flow) 
CD19 HIB19 Mouse APC BD 555415 20ul/test (Flow) 
CD3 SK7 Mouse APC-H7 BD 560275 20ul/test (Flow) 


















1 wt m del13p neg neg neg 1996
2 mut um norm pos pos pos 4665
3 wt m del13p neg neg neg 3329
4 wt um del13p neg pos neg 2580
5 wt m del13p pos neg neg 5523
6 wt um norm neg neg neg 2298
7 mut na del17p pos pos neg 4253
8 mut m del17p pos neg neg 4322
9 mut um norm pos pos pos 1437
10 mut um tris12 pos pos pos 2807
11 wt um norm neg neg pos 3449
12 wt um del11q neg pos neg 1671
13 mut um del17p pos pos pos 5597
14 wt um norm pos neg neg 31016
15 wt m tris12 pos neg neg 36209
16 wt um tris12 pos pos neg 22099
17 wt m del13p neg neg pos 2113
18 mut um tris12 pos pos pos 2313
19 wt m del17p neg neg pos 679
20 wt um del11q neg neg neg 2315
21 wt m norm neg neg pos 1296
22 wt na del13p neg neg neg 2640
23 wt um del13p pos pos pos 1595
24 wt um norm neg pos pos 2254
25 wt m norm neg neg neg 1801
26 wt m norm pos neg neg 2877
27 wt m del11q neg neg neg 1133
28 wt m del11q pos neg neg 1741
29 wt m norm neg neg neg 1242
30 mut um del17p pos pos pos 1857
31 wt na norm neg neg neg 3815
32 wt um norm pos pos pos 12058
33 wt m norm neg neg neg 1812
34 mut um tris12 pos pos pos 3655
35 wt m del13p neg neg neg 8044
36 wt m del13p neg neg neg 2439
37 wt m norm neg neg neg 4822
38 mut um tris12 pos pos neg 6212
39 wt m norm pos pos neg 15099
40 wt um norm neg pos neg 1475
41 wt m del13p neg neg neg 2556
42 wt m norm pos neg neg 1387
43 wt m del13p neg neg neg 939
44 wt m del13p neg neg neg 2200
45 mut um tris12 pos neg pos 2080
46 wt um norm neg neg neg 2432
47 wt um norm neg neg pos 2110
48 wt m del13p neg neg neg 3342
49 wt m norm neg neg neg 2478
50 wt m del13p pos neg neg 12184
51 wt um tris12 pos pos neg 12555
52 wt m del13p neg neg neg 2393
53 wt m del13p neg neg neg 901
54 wt m tris12 pos neg neg 32914
55 mut m norm neg neg neg 1366
56 wt um del13p pos neg pos 5099
57 wt um del11q neg pos neg 1004


















59 wt m del13p neg neg neg 2553
60 wt um del13p neg neg pos 4944
61 wt m del13p neg neg neg 3057
62 wt m del13p neg neg neg 1636
63 wt um tris12 neg neg pos 2892
64 wt m del13p neg neg pos 4821
65 wt m tris12 neg neg pos 3308
66 mut um del13p pos pos pos 3756
67 wt m del11q neg neg neg 2707
68 wt m tris12 pos neg pos 11727
69 wt um tris12 pos neg pos 7689
70 wt m del13p neg neg neg 5431
71 wt m del13p neg neg pos 2469
72 mut um norm pos neg pos 3098
73 wt m del13p neg neg neg 3411
74 wt m norm neg neg neg 1213
75 wt m norm neg neg neg 3012
76 wt m norm neg neg neg 2963
77 wt um del13p neg neg neg 3579
78 wt um del11q neg pos neg 4502
79 wt m del13p neg neg neg 1925
80 wt um del17p neg neg neg 3886
81 wt m del13p neg neg neg 4178
82 mut um norm neg pos pos 4342
83 wt m tris12 pos pos neg 11480
84 wt m del13p pos pos neg 4468
85 wt um del17p pos neg pos 1294
86 mut m del13p neg neg neg 5091
87 wt m del13p neg neg neg 5373
88 wt m del13p pos neg pos 8169
89 wt m del13p neg neg neg 1668
90 wt m tris12 pos neg pos 25468
91 wt um del13p neg neg pos 4815
92 wt um tris12 neg neg pos 2987
93 wt m del13p neg neg neg 3115
94 wt m norm neg neg pos 2769
95 mut m norm neg neg pos 2925
96 wt m del13p pos neg pos 4822
97 wt m norm pos pos pos 28751
98 wt na del17p pos neg neg 24530
99 wt m tris12 pos neg pos 29097
100 wt m norm neg neg neg 2290
101 wt m del13p neg neg neg 4124
102 wt m del11q neg neg pos 1588
103 wt na del17p pos neg neg 690
104 wt m del13p neg neg pos 5276
105 mut m del13p pos neg pos 979
106 wt na del17p pos neg pos 2431
107 wt m del13p neg neg pos 2093
108 wt m del17p neg neg neg 2368
109 wt m del13p pos pos neg 24048
110 wt um norm pos pos pos 2695
111 wt um norm pos pos pos 1767
112 mut na norm neg neg neg 1248
113 wt um del13p pos neg pos 7866
114 wt m del13p neg neg neg 7431
115 wt m del13p neg neg neg 2082
116 wt na del13p neg neg neg 1288
117 wt m del17p na na pos 5932
118 wt m del13p neg neg neg 1954


















120 wt na del17p neg neg neg 4230
121 mut um norm pos pos pos 1835
122 wt m del13p pos neg pos 3912
123 wt m del13p neg neg pos 3213
124 wt m del17p neg neg pos 3064
125 wt na del17p neg neg neg 1235
126 mut na del13p neg pos pos 1471
127 wt na del13p neg neg pos 2091
128 wt na del13p neg neg pos 2315
129 wt um norm pos neg pos 3720
130 wt na norm pos neg pos 3552
131 wt m norm pos pos pos 4600
132 wt m norm pos neg pos 2797
133 wt m del13p neg neg pos 3520
134 wt m norm neg neg pos 2380
135 mut m del13p neg neg pos 3951
136 wt m del13p neg neg pos 3354
137 wt na del13p neg neg pos 1916
138 wt um tris12 pos pos pos 2065
139 wt na del17p neg neg pos 1640
140 mut na tris12 pos neg pos 1844
141 wt na del13p neg neg pos 2470
142 wt m del13p neg neg neg 2320
143 wt um del13p pos neg pos 1108
144 wt m norm neg neg pos 2386
145 wt m del13p neg neg pos 3109
146 wt um del13p neg neg neg 2172
147 wt um del17p pos pos pos 1945
148 wt m del13p neg neg pos 3069
149 wt m del11q pos neg pos 20820
150 wt m del13p neg neg neg 2808
151 wt m del13p neg neg pos 1741
152 mut um del13p pos pos pos 2264
153 mut um norm neg pos pos 3504
154 wt m norm neg neg pos 1584
155 wt um del11q pos pos pos 3152
156 wt um norm neg neg pos 2506
157 wt m norm neg neg pos 2300
158 mut um del17p neg pos pos 2297
159 wt m norm pos pos pos 10889
160 wt m norm pos pos neg 6564
161 wt um del17p neg neg pos 3595
162 wt m del17p neg neg pos 2027
163 mut um del13p pos pos pos 3233
164 wt m del13p pos neg pos 2615
165 wt m del13p neg neg pos 1380
166 wt m del17p pos neg pos 9638
167 mut um tris12 pos pos pos 2126
168 wt um norm pos pos pos 4138
169 wt m norm neg neg pos 2378
170 wt um del17p neg neg pos 1773
171 wt m tris12 pos pos pos 26131
172 wt m del13p neg neg neg 1939
173 wt na del13p neg neg neg 1727
174 wt um del11q neg neg pos 3177
175 mut na del11q neg neg pos 3054
176 wt um del11q neg neg neg 2481
177 wt m tris12 pos pos pos 16810
178 mut um tris12 pos neg pos 2477
179 wt um del11q neg pos pos 3181


















181 wt um del13p neg neg pos 1600
182 mut m del13p neg neg pos 4406
183 wt m del17p neg neg neg 1894
184 wt um tris12 pos neg pos 1276
185 wt m del13p neg neg na 3512
186 mut um tris12 pos neg na 3282
187 wt um del13p neg pos na 1721
188 wt um norm neg neg pos 1651
189 wt m del13p neg neg pos 1356
190 wt m del13p neg neg pos 3865
191 wt m del13p neg neg pos 1583
192 mut um tris12 pos pos pos 5283
193 wt m tris12 pos pos pos 25248
194 wt um del13p neg neg pos 804
195 wt m del13p neg neg pos 5983
196 wt m del13p neg neg pos 3812
197 wt m del13p pos neg pos 3528
198 wt na del17p neg neg neg 4950
199 wt m del17p pos neg pos 20018
200 wt m del13p neg neg pos 2549
201 wt m del11q neg neg pos 4420
202 wt m tris12 pos pos pos 14291
203 wt m del17p neg neg pos 1833
204 wt m del17p neg neg pos 2054
205 mut m tris12 pos neg pos 4162
206 wt m tris12 pos pos pos 5402
207 mut um tris12 neg pos pos 1222
208 wt um del13p neg neg pos 1037
209 wt m tris12 pos neg pos 7621
210 mut um norm neg neg pos 1160
211 wt m del17p neg neg pos 1995
212 mut um del17p pos pos pos 1814
213 mut um norm pos pos pos 472
214 mut um del17p pos pos pos 1470
215 wt um norm pos pos pos 573
216 mut m norm neg pos pos 588
217 wt m del11q neg neg pos 1377
218 wt um del17p neg neg pos 1844
219 wt m del13p pos neg pos 2090
220 wt m norm pos neg pos 1359
221 wt m norm pos neg pos 963
222 mut um norm pos neg pos 228
223 wt m norm pos neg neg 3255
224 wt m norm pos pos pos 9336
225 wt um del13p pos pos pos 1085
226 wt um norm pos pos pos 8508
227 wt m del13p neg neg pos 984
228 wt m del17p neg neg pos 3804
229 wt m norm pos neg pos 1541
230 mut um tris12 pos neg pos 2661
231 wt m del17p neg neg pos 1602
232 mut um tris12 pos pos pos 772
233 wt um del11q neg neg pos 478
234 mut um tris12 pos pos pos 4192
235 wt m norm neg neg pos 3234
236 wt na del13p neg neg neg 2426
237 wt m norm neg neg neg 825
238 wt um del11q pos pos pos 521
239 wt m del17p pos neg pos 11921
240 wt m del13p pos pos pos 13057


















242 wt m tris12 neg neg pos 1734
243 wt m tris12 neg neg pos 901
244 wt m tris12 pos pos pos 5737
245 wt m del13p neg neg neg 837
246 wt um del13p neg pos pos 3699
247 wt m del11q pos neg neg 963
248 wt m del13p pos pos pos 11136
249 wt m del11q pos pos pos 6412
250 wt m del13p pos neg neg 1272
251 wt m del13p neg neg neg 1885
252 wt m norm pos neg pos 6778
253 mut um tris12 pos neg pos 1299
254 wt m del13p pos neg pos 561
255 wt m norm na na pos 11484
256 wt um tris12 pos neg pos 10704
257 wt um del17p pos neg pos 1326
258 wt m del13p neg neg pos 1218
259 mut um del11q neg neg pos 995
260 wt m del13p neg neg pos 1472
261 wt m del17p pos neg pos 17614
262 wt m del13p neg neg pos 801
263 wt m del13p neg neg pos 2076
264 wt um tris12 pos pos pos 2395
265 wt m del17p pos neg pos 834
266 wt um del17p neg pos pos 525
267 wt m norm neg neg pos 695
268 wt um norm pos neg pos 904
269 wt m del13p neg neg neg 1621
270 mut um norm pos pos pos 1702
271 wt m del13p neg neg pos 1296
272 wt m del17p neg neg pos 568
273 wt m del13p neg neg pos 434
274 wt m del13p neg neg pos 2049
275 wt um tris12 pos neg pos 5533
276 mut m del13p pos neg pos 2646
277 wt m del13p neg neg pos 996
278 wt m del17p pos neg pos 1469
279 wt um del17p pos neg pos 2647
280 wt um tris12 pos pos pos 5670
281 wt na del13p neg neg pos 1540
282 wt m del17p neg neg pos 3321
283 wt m norm neg neg pos 711
284 wt um norm neg pos pos 1194
285 wt um del11q neg pos pos 1121
286 mut um tris12 pos pos pos 1686
287 mut um del13p neg neg pos 803
288 wt m norm pos neg pos 646
289 mut um tris12 pos pos pos 1945
290 mut na norm neg pos pos 796
291 mut um del13p pos pos pos 1007
292 wt um norm pos pos pos 642
293 mut m tris12 neg neg pos 3437
294 wt um norm pos pos pos 2158
295 wt um tris12 neg neg pos 186
296 wt m del13p neg neg neg 205
297 wt m del13p neg neg pos 1957
298 wt m del13p neg neg neg 3616
299 wt m del13p pos neg pos 8324
300 wt m del13p neg neg neg 698
301 wt m del13p neg neg neg 1255


















303 wt um del17p neg pos pos 1904
304 wt na del13p neg neg neg 141
305 mut um del13p pos pos neg 54
306 wt m del13p neg neg neg 713
307 wt m del13p neg neg pos 1038
308 mut um tris12 pos neg pos 1516
309 wt m norm neg neg pos 1132
310 mut um del13p neg pos pos 2205
311 wt m norm pos neg pos 18411
312 wt m tris12 pos neg neg 6021
313 mut m del13p neg neg neg 1783
314 wt um del11q neg neg pos 1956
315 wt m del13p neg neg neg 419
316 wt um del13p neg neg neg 2437
317 wt m del13p neg neg neg 2184
318 wt um norm neg neg neg 752
319 wt m del13p neg neg neg 1408
320 wt um tris12 pos pos neg 3187
321 wt um del11q neg pos pos 1413
322 mut um tris12 pos pos pos 709
323 mut um del11q neg pos pos 2355
324 wt m del13p pos neg neg 17032
325 wt um norm neg pos pos 1478
326 wt m del13p neg neg neg 993
327 wt m norm neg pos pos 1207
328 wt m del13p neg neg neg 1639
329 wt m del13p neg neg neg 3053
330 wt m del13p neg neg pos 2415
331 mut um del13p neg neg pos 853
332 wt um norm pos pos pos 957
333 wt m tris12 neg neg neg 1339
334 wt m norm neg neg neg 1094
335 wt m del13p neg neg neg 739
336 wt um del11q neg neg pos 411
337 wt m norm neg neg neg 578
338 wt m del13p neg neg neg 1962
339 wt m norm neg neg neg 1233
340 mut um tris12 pos pos pos 1455
341 wt m norm neg pos neg 751
342 mut um del13p neg pos pos 610
343 wt m del13p neg neg pos 1647
344 wt m tris12 pos neg neg 2080
345 wt m del13p neg neg neg 615
346 mut um del17p pos pos pos 2434
347 wt m del13p neg neg pos 2598
348 wt um del11q pos pos pos 2314
349 wt m norm neg neg pos 358
350 wt m del13p neg neg pos 2481
351 wt um norm neg neg pos 588
352 wt m del13p neg neg pos 1330
353 wt m del13p neg neg neg 910
354 wt um del11q neg neg pos 1630
355 wt m norm neg neg pos 3940
356 wt um del11q neg neg pos 554
357 wt m norm neg neg pos 258
358 wt m norm pos neg neg 1112
359 wt um del13p pos neg pos 2046
360 wt na del13p neg neg pos 918
361 wt m del13p neg neg pos 2356
362 wt m del13p neg neg pos 1615


















364 wt um norm pos pos pos 4609
365 mut um tris12 pos pos pos 3793
366 wt um del13p neg pos pos 3434
367 wt m tris12 pos neg pos 4501
368 wt um norm pos pos pos 2256
369 mut um norm pos pos pos 2302
370 wt m norm neg neg pos 1716
371 wt m del13p neg neg pos 591
372 wt m del17p pos neg pos 6978
373 wt um del17p pos neg pos 2738
374 wt um del11q neg neg pos 802
375 wt m del13p neg neg pos 2553
376 wt um del11q neg neg neg 1796
377 wt m tris12 pos pos neg 10857
378 wt m del13p pos neg pos 2254
379 wt m del17p neg neg pos 2526
380 wt m norm pos neg pos 12610
381 wt m tris12 neg neg pos 3331
382 wt m del13p pos neg pos 14634
383 wt m norm neg neg pos 779
384 wt m del13p neg neg neg 1230
385 wt um norm pos neg pos 793
386 wt m del13p neg neg pos 1511
387 wt m norm pos neg pos 22258
388 wt m del13p pos neg pos 10987
389 wt m del13p pos neg pos 2003
390 mut um del11q neg neg pos 3086
391 wt um del13p neg neg pos 1391
392 wt m del13p neg neg pos 1524
393 wt m norm pos neg pos 17394
394 wt m tris12 pos pos pos 10278
395 wt m del13p neg neg pos 2707
396 wt m del13p neg neg neg 2260
397 wt m del13p neg neg pos 3220
398 wt m del13p neg neg neg 1155
399 wt m del11q neg pos pos 3981
400 mut um tris12 pos pos pos 2443
401 mut um del17p pos neg neg 1765
402 mut m tris12 neg pos pos 2683
403 wt m del13p neg neg neg 2038
404 wt m norm neg neg neg 1414
405 wt um norm pos pos pos 3447
406 wt m tris12 pos pos pos 6231
407 wt m del13p neg neg pos 2422
408 wt m norm neg neg neg 2969
409 wt m del13p neg neg neg 3289
410 wt m del13p neg neg neg 1572
411 wt m del17p neg neg neg 548
412 wt m norm neg pos pos 989
413 wt m del13p neg neg neg 1205
414 wt m del13p pos pos pos 2020
415 wt m del13p neg neg neg 2950
416 wt m norm neg neg neg 1185
417 wt m del13p na na neg 4602
418 wt m norm pos pos pos 2251
419 wt um tris12 pos pos pos 1953
420 wt m del17p pos pos neg 2754
421 wt m del13p neg neg neg 1883
422 wt um norm neg neg pos 1163
423 mut um del11q neg pos pos 2334


















425 wt m del13p neg neg neg 1659
426 wt m del13p neg neg neg 3500
427 mut um tris12 pos pos pos 554
428 wt m norm neg neg neg 1638
429 wt um del13p neg neg pos 1586
430 mut um tris12 pos pos pos 2404
431 wt um norm neg neg neg 2743
432 mut um del11q neg neg neg 2366
433 wt um del13p neg neg neg 1700
434 wt um tris12 neg neg neg 622
435 wt m del13p pos pos neg 1808
436 wt um tris12 pos pos pos 3374
437 wt m tris12 pos pos neg 10364
438 wt m norm pos neg neg 3822
439 wt m del13p neg neg neg 3175
440 wt um del13p neg neg pos 968
441 wt um del11q neg pos pos 1076
442 wt m del13p neg neg neg 1029
443 wt m norm pos neg neg 7829
444 wt um del13p neg neg neg 628
445 wt um del11q neg pos pos 1800
446 wt m del13p neg neg neg 1226
447 wt m del13p neg neg neg 1128
448 wt m del13p neg neg pos 2453
449 wt um del13p neg pos pos 3874
450 wt um del17p neg pos pos 2227
451 wt na del13p neg neg neg 1650
452 wt m norm neg neg pos 9282
453 wt m norm neg neg neg 2168
454 wt m del13p neg neg pos 1680
455 mut m del17p neg neg pos 4669
456 mut m tris12 pos pos neg 4053
457 mut m del13p neg neg neg 1581
458 wt um norm neg neg pos 1068
459 mut um tris12 pos neg pos 1450
460 wt um norm neg neg neg 2305
461 mut um norm pos pos pos 1711
462 mut um del11q pos pos pos 1471
463 wt na norm neg neg neg 1450
464 wt m norm neg neg neg 27
465 wt um norm pos neg neg 2847
466 mut m norm pos pos neg 2177
467 wt m del13p neg neg neg 1362
468 mut um tris12 pos neg pos 897
469 wt m norm pos pos neg 12362
470 mut um del13p pos pos pos 2242
471 wt um tris12 pos pos pos 3111
472 wt um norm neg neg pos 391
473 wt m tris12 pos pos neg 11468
474 wt m del13p neg neg neg 1801
475 wt m del17p neg neg neg 949
476 wt m tris12 pos neg pos 5943
477 mut m del13p neg neg neg 1709
478 wt m norm neg neg neg 3772
479 wt m norm pos neg neg 15720
480 wt um del13p neg pos neg 655
481 wt um del13p pos neg neg 1350
482 wt um del17p pos pos neg 15505
483 mut um tris12 pos pos neg 8648
484 wt um del11q neg neg pos 1085


















486 wt m del13p neg pos pos 3246
487 wt m del13p neg neg pos 1572
488 wt m tris12 pos pos pos 8510
489 wt m del13p neg neg neg 1285
490 wt m del13p neg neg neg 4678
491 wt um norm pos neg pos 11253
492 wt m norm pos neg neg 1968
493 wt m tris12 pos neg neg 9784
494 wt um del13p neg neg pos 1430
495 wt m tris12 pos neg neg 12251
496 wt na norm pos neg neg 2014
497 mut um tris12 pos pos pos 1062
498 wt m norm neg neg neg 1129
499 mut um del13p neg neg pos 2484
500 wt um del13p neg neg pos 2216
501 wt m del13p pos pos pos 2664
502 wt m del13p pos neg neg 1661
503 wt m norm neg neg neg 1469
504 wt m del13p neg neg pos 2075
505 wt m norm pos neg neg 2263
506 mut um del13p pos neg pos 579
507 wt m norm pos pos neg 1350
508 wt m norm pos neg neg 15024
509 wt m del13p neg neg neg 772
510 wt um tris12 pos pos pos 3031
511 mut um tris12 pos neg pos 7355
512 wt um del17p neg neg neg 890
513 mut na del13p neg neg neg 2681
514 wt m norm neg neg pos 1281
515 wt um del13p neg neg neg 234
516 wt m norm pos neg pos 11740
517 wt m del13p neg neg neg 3385
518 wt um del11q pos pos pos 1720
519 wt m norm neg neg neg 2423
520 wt m del13p neg neg neg 1750
521 wt um del13p neg neg neg 1335
522 wt m del13p neg neg neg 1543
523 wt m norm pos neg neg 12313
524 wt um norm pos pos pos 2466
525 wt um tris12 pos neg pos 4008
526 wt m del13p neg neg neg 2030
527 mut um del13p neg pos pos 2289
528 wt um tris12 pos pos pos 2382
529 wt m del13p neg neg neg 1817
530 wt m del13p pos neg na 882
531 wt um norm pos pos pos 1786
532 wt m del13p neg neg neg 3301
533 wt um norm pos neg pos 1542
534 wt um del11q neg pos pos 2212
535 mut um tris12 pos neg pos 989
536 wt um del11q neg neg neg 3664
537 wt m del13p pos neg pos 5189
538 mut um norm pos pos pos 2778
539 wt um tris12 pos neg neg 6035
540 wt um del17p pos pos pos 653
541 wt um norm pos pos pos 2328
542 wt m del13p neg neg neg 759
543 wt m norm neg neg neg 1644
544 wt m tris12 na na neg 16209
545 mut m del13p neg neg neg 1554


















547 mut um tris12 pos neg pos 1931
548 wt m norm neg neg neg 1467
549 wt m norm neg neg neg 19299
550 wt um tris12 pos pos pos 10444
551 wt m del13p neg neg neg 1730
552 mut um tris12 pos pos pos 2255
553 wt m del13p neg neg neg 2125
554 wt um tris12 pos neg pos 2469
555 mut m del11q neg pos neg 1095
556 wt m del13p neg neg neg 996
557 wt um del17p neg neg neg 480
558 wt um norm neg neg pos 234
559 mut um del11q neg neg pos 2188
560 wt m tris12 pos pos neg 7258
561 wt m del13p neg neg neg 1026
562 wt um norm pos neg neg 1569
563 wt m del11q pos pos neg 13620
564 wt m del13p neg neg pos 2356
565 wt m del13p neg neg neg 4434
566 wt m del13p pos neg pos 12399
567 wt m del13p neg neg pos 1846
568 wt m norm neg neg neg 864
569 wt um del13p pos pos neg 320
570 wt m del13p neg neg na 1695
571 mut m tris12 pos neg na 4270
572 wt um norm pos neg na 697
573 wt um tris12 pos pos pos 2776
574 mut um norm pos pos pos 419
575 wt m norm pos neg pos 21743
576 mut um tris12 neg neg pos 522
577 mut um del17p pos neg neg 21
578 wt um del11q pos neg pos 81
579 mut um tris12 pos neg na 1575
580 wt um del11q neg neg na 3486
581 wt m del13p neg neg pos 1632
582 wt m norm neg neg pos 1374
583 wt m del17p pos neg pos 12828
584 wt um del11q neg pos pos 2806
585 mut um del13p pos neg neg 1830
586 mut um tris12 pos pos pos 1665
587 wt m tris12 pos pos na 9848
588 wt m del13p pos na neg 17024
589 wt m del17p pos pos pos 2356
590 wt m del13p neg neg neg 2875
591 mut um del17p pos pos pos 3091
592 wt na del17p pos neg pos 7630
593 wt m norm neg neg pos 2287
594 wt m del13p neg neg pos 3160
595 wt m tris12 pos pos neg 19559
596 wt m del17p neg neg neg 615
597 mut um tris12 pos pos pos 1202
598 wt um del13p neg neg neg 1655
599 mut um del11q neg pos na 2407
600 wt um del13p neg neg neg 2624
601 wt m del13p neg neg pos 2644
602 wt na norm neg neg pos 1068
603 wt um del11q neg neg neg 621
604 wt um del11q neg pos pos 2127
605 wt m tris12 pos neg neg 2861
606 wt m del13p neg neg neg 1159


















608 wt m del13p neg neg neg 632
609 wt na norm neg neg neg 1784
610 wt m del17p pos neg neg 1874
611 wt na norm pos pos neg 22500
612 wt m del13p neg neg na 1048
613 wt um tris12 pos neg na 904
614 wt m norm pos neg na 8337
615 wt um del13p neg neg na 1964
616 wt m del13p neg neg na 1435
617 wt um del13p neg neg na 2933
618 wt m del13p neg neg neg 1435
619 wt um norm neg neg na 10098
620 mut um del11q pos pos na 2396
621 wt m del13p neg neg na 2906
622 wt m del13p neg neg na 2052
623 wt m norm neg neg na 2686
624 wt m del13p pos pos na 3610
625 wt m del17p neg neg na 3626
626 wt um del17p neg neg na 1023
627 wt m del13p pos pos na 1994
628 wt m del11q pos pos na 11905
629 mut um del13p neg pos na 1277
630 wt um del13p pos neg na 1064
631 wt m del13p neg neg na 1798
632 wt m norm neg neg na 809
633 wt um del11q neg neg na 2844
634 wt m norm neg neg na 2141
635 wt um tris12 pos pos na 41
636 wt m del13p neg neg na 654
637 wt um norm neg pos na 3043
638 wt m del13p neg neg na 2140
639 wt m del13p neg neg na 1853
640 mut um tris12 pos pos na 2438
641 wt m del13p neg neg na 1566
642 wt m tris12 pos pos na 3470
643 wt m norm neg neg na 1471
644 wt um del11q neg neg na 1820
645 wt m del13p pos neg na 10082
646 wt na del11q pos neg na 3243
647 wt um tris12 pos neg na 1801
648 wt um del11q neg pos na 1840
649 wt um del13p neg neg pos 2508
650 mut um norm pos pos na 1957
651 mut um del13p pos pos pos 2077
652 mut m norm neg neg na 2960
653 mut m norm neg neg na 1448
654 wt m tris12 pos neg na 9933
655 mut um tris12 pos pos na 1801
656 wt m tris12 pos neg na 13955
657 mut um del11q pos neg na 1610
658 wt um del13p neg neg na 2632
659 wt m del13p pos neg na 5602
660 wt m del13p neg neg na 2898
661 wt m del13p neg neg na 1189
662 mut m del11q pos neg pos 2360
Abbreviations: ID #: identification number, NOTCH1  status: wt, NOTCH1  wild type, mut, NOTCH1  mutated; IGHV  status: um, IGHV 
unmutated, m, IGHV  mutated; FISH: norm, normal karyotype; CD49d, CD38, ZAP70 expression: pos, positive, neg, negative; na, not 
available.
a: as determined by next generation sequencing (NGS). b: IGHV status was established according to the conventional cut-off, as reported 
in ref. 9. c: FISH status was determined according to ref. 13. d: CD49d, CD38 and ZAP70 expression are reported as percentage of 
positive cells (cutoff of CD49d and CD38 expression: ≥ 30% of positive cells; cutoff of ZAP70 expression: ≥ 20% of positive cells), as in 
ref. 9. e: MFI values are substracted from the values of irrelevant isotype-matched antibody.
Table S7. NOTCH1  mutation features of the NOTCH1  mutated cohort (116 cases).
ID# Mutation_1 Mutation_2 Mutation_3 Verification
2 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 8.1% ARMS-PCR
7 g.139390152T>C; c.*7668+371A>G;  49.4% RT-PCR
8 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 48.3% ARMS-PCR
9 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 11.5% ARMS-PCR
10 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 3.5% ARMS-PCR
13 g.139390765CG>C; c.7425delC; p.V2476*; 35.8% Sanger
18 g.139390152T>C; c.*7668+371A>G; 36.5% RT-PCR
30 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 3.2% ARMS-PCR
34 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 10.5% ARMS-PCR
38 g.139390797G>GGC; c.7392_7393insGC; p.P2465Afs*13; 43.3% Sanger
45 g.139390152T>C; c.*7668+371A>G; 35.6% RT-PCR
55 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 2.0% ARMS-PCR
66 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 3.7% ARMS-PCR
72 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 33.4% ARMS-PCR
82 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 19.5% ARMS-PCR, Sanger
86 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 15.4% ARMS-PCR
95 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 4.3% ARMS-PCR
112 g.139390152T>C; c.*7668+371A>G; 46.3% NGS
121 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 8.1% ARMS-PCR
126 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 1.5% ARMS-PCR
135 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 83.0% ARMS-PCR
140 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 54.5% ARMS-PCR
152 g.139390152T>C; c.*7668+371A>G; 44.0% RT-PCR
153 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 39.0% ARMS-PCR
158 g.139390152T>C; c.*7668+371A>G; 22.5% g.139390897AC>A; c.7293delG; p.R2431fs*4; 12.9% NGS, Sanger
167 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 34.9% ARMS-PCR, Sanger
175 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 4.6% ARMS-PCR
178 g.139390152T>C; c.*7668+371A>G; 33.9% RT-PCR
182 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 4.6% ARMS-PCR
186 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 41.6% ARMS-PCR
192 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 2.5% ARMS-PCR
205 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 19.1% ARMS-PCR
207 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 3.5% ARMS-PCR, Sanger
212 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 43.0% ARMS-PCR
213 g.139390929AC>A; c.7261delG; p.V2421*; 32.7% Sanger
214 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 46.9% ARMS-PCR
216 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 3.2% ARMS-PCR
222 g.139391369GGA>G; c.6820_6821delTC; p.S2274Pfs*79; 50.0% Sanger
230 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 18.9% ARMS-PCR
232 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 38.6% ARMS-PCR
234 g.139390145T>C; c.*7668+378A>G; 5.8% g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*; 3.2% RT-PCR, ARMS-PCR
253 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 18.7% ARMS-PCR
259 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 47.3% ARMS-PCR
270 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 41.4% ARMS-PCR, Sanger
276 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 1.2% NGS*
286 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 31.1% ARMS-PCR, Sanger
287 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 5.2% ARMS-PCR
289 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 39.6% ARMS-PCR
290 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 6.4% g.139390791GA>G c.7399delT p.S2467Rfs*10 5.7% ARMS-PCR, NGS
291 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 40.2% ARMS-PCR
293 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 1.1% NGS*
305 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 2.9% ARMS-PCR
308 g.139390684G>A; c.7507C>T; p.Q2503*; 2.1% NGS
310 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 36.6% ARMS-PCR
313 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 1.3% ARMS-PCR
322 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 3.0% ARMS-PCR
ID# Mutation_1 Mutation_2 Mutation_3 Verification
323 g.139390145T>C; c.*7668+378A>G; 4.1% RT-PCR
331 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 23.3% ARMS-PCR
340 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 1.0% NGS*
342 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 1.1% NGS*
346 g.139390861G>A; c.7330C>T; p.Q2444*; 12.5% Sanger
365 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 35.8% ARMS-PCR
369 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 1.3% g.139391645CTTCTTCCTCCGTGCCT>C;
c.6530_6545delAGGCACGGAGGAAGAA; p.K2177Sfs*66; 5.5% ARMS-PCR, NGS
390 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 2.9% ARMS-PCR
400 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 26.2% ARMS-PCR, Sanger
401 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 77.0% ARMS-PCR
402 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 33.0% ARMS-PCR
423 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 31.3% ARMS-PCR
424 g.139390152T>C; c.*7668+371A>G; 14.1% RT-PCR
427 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 45.7% ARMS-PCR, Sanger
430 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 37.9% ARMS-PCR, Sanger
455 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 2.2% ARMS-PCR
456 g.139390152T>C; c.*7668+371A>G; 49.9% NGS
457 g.139390152T>C; c.*7668+371A>G; 20.4% RT-PCR
459 g.139390152T>C; c.*7668+371A>G; 49.3% RT-PCR
461 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 41.3% ARMS-PCR, Sanger
462 g.139390152T>C; c.*7668+371A>G; 20.5% RT-PCR
466 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 24.2% g.139390861G>A; c.7330C>T; p.Q2444*; 25.8% ARMS-PCR, Sanger
468 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 3.5% ARMS-PCR
470 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 42.0% ARMS-PCR
477 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 1.8% ARMS-PCR
483 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 5.2% ARMS-PCR
497 g.139390152T>C; c.*7668+371A>G; 49.9% RT-PCR
499 g.139390145T>C; c.*7668+378A>G;  44.8% RT-PCR
506 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 16.7% ARMS-PCR
511 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 1.8% ARMS-PCR
513 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 1.6% ARMS-PCR
527 g.139390152T>C; c.*7668+371A>G; 6.7% RT-PCR
535 g.139390861G>A; c.7330C>T; p.Q2444*; 18.3% Sanger
538 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 36.6% ARMS-PCR
545 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 12.9% ARMS-PCR
547 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 13.8% ARMS-PCR
552 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 5.6% ARMS-PCR, Sanger
555 g.139390152T>C; c.*7668+371A>G;  12.1% RT-PCR
559 g.139390734G>T; c.7457C>A; p.S2486*; 1.6% NGS
571 g.139390873G>A; c.7318C>T; p.Q2440*; 39.2% Sanger
574 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 2.4% g.139390648_2C>A; c.7543G>T; p.E2515*; 35.9% ARMS-PCR, Sanger
576 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 1.5% ARMS-PCR
577 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 33.4% ARMS-PCR
579 g.139390861G>A; c.7330C>T; p.Q2444*; 30.1% Sanger
585 g.139390145T>C; c.*7668+378A>G; 40.1% RT-PCR
586 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 1.4% g.139390846TG>T; c.7344delC; p.S2449Afs*28; 19.1% ARMS-PCR, Sanger
591 g.139390145T>C; c.*7668+378A>G;  27.7% g.139390675C>A; c.7516G>T; p.E2506*; 12.6% RT-PCR, Sanger
597 g.139390873G>A; c.7318C>T; p.Q2440*; 7.5% NGS
599 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 46.3% ARMS-PCR, Sanger
607 g.139390152T>C; c.*7668+371A>G; 18.0% g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 2.9% RT-PCR, NGS
620 g.139390145T>C; c.*7668+378A>G; 13.0% RT-PCR
629 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 1.7% ARMS-PCR
640 g.139390152T>C; c.*7668+371A>G; 45.2% RT-PCR
650 g.139390145T>C; c.*7668+378A>G;  19.6% g.139390684G>A; c.7507C>T; p.Q2503*; 5.5% g.139390690G>A; c.7501C>T; p.Q2501*; 5.1% RT-PCR, NGS
651 g.139390152T>C; c.*7668+371A>G; 47.4% RT-PCR
652 g.139390659GTGAGGAAGGGGTGCTCAGGCACC>G;
c.7509_7532delGGTGCCTGAGCACCCCTTCCTCA; p.T2511Rfs*24; 2.6% NGS
ID# Mutation_1 Mutation_2 Mutation_3 Verification
653 g.139390152T>C; c.*7668+371A>G; 31.4% NGS
655 g.139390716G>T; c.7475C>A; p.S2492*; 3.6% NGS
657 g.139390648CAG>C; c.7541_7542delCT; p.P2514Rfs*4; 3.4% ARMS-PCR
662 g.139390721G>C; c.7470C>G; p.Y2490*; 2.9% NGS
ID#: identification number.
NGS*: preliminarily detected by ARMS-PCR; VAF computed by analysis of raw NGS data.
Mutation description: genomic ("g" relative to human genome assembly hg19), mRNA ("c"), aminoacidic ("p") substitutions and variant allele frequency (VAF, "%") are reported. 
ARMS-PCR, mutation verified by Amplification Refractory Mutation System; NGS, mutation verified by an independent round of NGS (amplification and sequencing); Sanger, mutation verified by Sanger sequencing; RT-PCR, mutation verified by specific PCR 
for aberrant splicing on cDNA.
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Supplemental figure legends 
Figure S1. Validation of NGS strategy to detect NOTCH1 mutations. (A) Dilution experiments 
to determine the sensitivity of NGS approach to call low frequency mutations. Serial dilutions were 
made by mixing with normal DNA from a healthy donor either the DNA of one of 3 CLL cases 
carrying NOTCH1 mutations (i.e. 1 case with g.139390152T>C, 1 case with g.139390648CAG>C, 
and 1 case with g.139390873G>A) or the DNA of a CLL case carrying a SNP in the NOTCH1 gene 
(i.e. g.139391636G>A, rs2229974). As reported in supplemental materials and methods, only 
somatic mutations truncating the NOTCH1 protein were included in the analysis. (B) Threshold of 
Sanger sequencing detection. Shown are screenshots of Integrative Genomics Viewer (IGV), and 
Sanger sequencing electropherograms (inset), of 3 representative NOTCH1 mutations detected by 
NGS, and investigated by Sanger sequencing. NOTCH1 mutations with a VAF<12% were 
confirmed by a second independent NGS experiment (see Table S7). ID, mutation VAF and 
coverage (depth), corresponding to each NOTCH1-mut cases is reported. (C) Representative gel 
image of ARMS-PCR verification for c.7541-7542delCT mutation (g.139390648CAG>C). 
Representative results of the ARMS PCR assay showing 3 CLL samples that scored positive and 1 
sample that scored negative for c.7541-7542delCT mutation. Negative sample shows a normal band 
of 284 base pair (bp, single arrow). Positive samples show an additional band of 183 bp (double 
arrow). Molecular weight is the 100 bp ladder. Camera: Gel Doc EZ, BioRad; image acquisition 
software: Image Lab 3.0, BioRad. ID and mutation VAF corresponding to each NOTCH1-mut cases 
is reported. (D) RT-PCR to detect the presence of the aberrant spliced transcript in 3′ UTR 
NOTCH1-mut cases. RT-PCR amplification showing the expected 719-base pair (bp) band in a 
NOTCH1-wt case, and an additional smaller band in cases carrying 3′ UTR NOTCH1 mutations. 
This amplification was performed in 23/26 3′ UTR NOTCH1-mut cases. In 3/26 3′ UTR NOTCH1-
mut cases, in which RNA sample was not available, a second independent NGS experiment was 
performed to confirm the presence of the 3′ UTR NOTCH1 mutations (see Table S7). Molecular 
weight is the 100 bp ladder. Camera: Gel Doc EZ, BioRad; image acquisition software: Image Lab 
3.0, BioRad. ID and mutation VAF corresponding to each NOTCH1-mut cases is reported. (E) 
Frequencies of clonal (i.e. with VAF≥12%, subdivided in <35% or ≥35%) and subclonal (i.e. with 
VAF<12%) mutations, among the group of 26 3′ UTR NOTCH1 mutations or the group of 101 
coding NOTCH1 mutations. Data were analyzed using chi-square test. 
Figure S2. Western blot of NOTCH1 and CD20 protein expression according to NOTCH1 
mutational status. (A) Western blot showing total NOTCH1 protein expression (transmembrane 
NOTCH1 and NICD) in representative CLL cases, i.e. in 4 NOTCH1-wt cases, 3 coding NOTCH1-
mut cases (2 cases with the g.139390648CAG>C, c.7541-7542delCT, p.P2514Rfs*4; 1 case with 
the g.139390929AC>A, c.7261delG, p.V2421*), and 7 3′ UTR NOTCH1-mut cases (5 cases with 
the g.139390152T>C, c.*7668+371A>G; 2 cases with the g.139390145T>C, c.*7668+378A>G). β-
actin was used as loading control. (B) Western blot showing CD20 (L26 epitope) protein expression 
by using high antibody concentrations (anti-CD20, dilution 1/500, and anti-mouse secondary 
antibody, dilution 1/1000, see Table S5) at three different exposure times (i.e. 15 seconds, 4 minutes 
and 20 minutes). CD20 expression was investigated in 3 NOTCH1-wt cases, 3 coding NOTCH1-
mut cases (2 cases with the g.139390648CAG>C, c.7541-7542delCT, p.P2514Rfs*4; 1 case with 
the g.139390929AC>A, c.7261delG, p.V2421*), and 7 3′ UTR NOTCH1-mut cases (5 cases with 
the g.139390152T>C, c.*7668+371A>G; 2 cases with the g.139390145T>C, c.*7668+378A>G). 
Figure S3. CD20 expression by flow cytometry in CLL cases. (A) Bar graphs showing CD20 
protein expression levels, in CLL cases according to cytogenetic abnormalities as evaluated by flow 
cytometry. Bar graphs represent mean values, error bars represent 95% CI. Norm, normal
24 
karyotype; del13q, 13q deletion; tris12, trisomy 12; del11q, 11q deletion; del17p, 17p deletion. 
(B) Dot plots showing CD20 expression, as evaluated by flow cytometry using a FITC-
conjugated anti-CD20 antibody, in prototypic 3′ UTR NOTCH1-mut cases, coding NOTCH1-























































































































































































































7.6 13.6 10.3 8.3
5 3.8 7 4.7 4.1
2.5 2.1 3 2.6 2.3
1.25 1.3 1.3 1.5 1.4
0.625 n.c. n.c. n.c. n.c.
































































































coding 3ʹ UTR 
n (%) n (%)
subclonal <12% 50 (49.5%) 3 (11.5%)
clonal <35% 25 (24.8%) 11 (42.3%)






























































































































































































































































































NOTCH1-wt Coding NOTCH1-mut3ʹ UTR NOTCH1-mut 
leukemia 
associated with low CD20 expression levels in chronic lymphocytic 




Valter Gattei, and Michele Dal Bo 
Raimondo, Davide Rossi, Gianluca Gaidano, Giovanni Del Poeta,
Chiarenza, Francesco Zaja, Gabriele Pozzato, Francesco Di 
Zucchetto, Massimo Degan, Paolo Macor, Giovanni D'Arena, Annalisa
Vanessa Bravin, Pietro Bulian, Francesca Maria Rossi, Antonella 
Tamara Bittolo, Federico Pozzo, Riccardo Bomben, Tiziana D'Agaro,
Intramural Program, Centro di Riferimento Oncologico, Aviano, Italy (VG). 
Pramaggiore Group, Italy (VG); Fondazione per la Vita di Pordenone, Italy (MDB); 5x1000
Italy; Associazione Italiana contro le Leucemie, linfomi e mielomi (AIL), Venezia Section, 
GR-2011-02346826 (AZ), no. GR-2011-02351370 (MDB), Ministero della Salute, Rome,
RF-2011-02349712 (GG), Progetto Giovani Ricercatori no. GR-2011-02347441 (RB), no. 
1000 No. 10007 (GG); Progetto Ricerca Finalizzata I.R.C.C.S. no. RF-2010-2307262 (VG),
Investigator Grants IG-17622 (VG), and Special Program Molecular Clinical Oncology 5 x 
 Supported in part by the Associazione Italiana Ricerca Cancro (AIRC),Disclosures:
interpreted data, and wrote the manuscript. 
samples and contributed to writing the manuscript, VG and MDB designed the study, 
research, GDA, AC, FZ, GP, FDR, DR, GG, GDP provided well characterized biological
performed the research, RB, TDA, VB, PB, FMR, AZ, MD, PM contributed to perform the 
 TB and FP contributed to writing the manuscript, analyzed the data andContributions:
 Haematologica HAEMATOL/2016/162594 Version 3
